Alendronate for use in the treatment of osteoporosis
Details for Australian Patent Application No. 2007211965 (hide)
International Classifications
Event Publications
13 September 2007 Complete Application Filed
20 September 2007 Application Open to Public Inspection
Published as AU-B-2007211965
15 May 2008 Application Accepted
Published as AU-B-2007211965
4 September 2008 Opposition Lodged
Apotex Pty Ltd has lodged an opposition against Merck & Co., Inc.
13 November 2008 Opposition Withdrawn
The opposition by Apotex Pty Ltd against Merck & Co., Inc has been withdrawn.
13 November 2008 Opposition Withdrawn - Proceed to Sealing
The opposition by Apotex Pty Ltd against Merck & Co., Inc has been withdrawn and the application will now proceed to sealing.
20 November 2008 Standard Patent Sealed
21 January 2010 Amendment Made
The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.
11 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser